Estrogen-receptor status and response to chemotherapy

@article{2006EstrogenreceptorSA,
  title={Estrogen-receptor status and response to chemotherapy},
  author={},
  journal={Nature Clinical Practice Oncology},
  year={2006},
  volume={3},
  pages={350-350}
}
Patients with estrogen-receptor (ER)-positive breast cancer treated with appropriate endocrine therapy (e.g. tamoxifen) have much better prognoses than those with ER-negative tumors. ER status might also be useful in predicting benefit from adjuvant chemotherapy, with recent trials indicating that patients with ERnegative tumors might respond better to… CONTINUE READING